首页> 外文期刊>Nepal Journal of Obstetrics and Gynaecology >Comparative study on safety and efficacy of cervical ripening agents misoprostol and dinoprostone in the induction of labour
【24h】

Comparative study on safety and efficacy of cervical ripening agents misoprostol and dinoprostone in the induction of labour

机译:宫颈成熟剂米索前列醇和地诺前列酮在引产中的安全性和有效性比较研究

获取原文
           

摘要

Aim: To compare the safety and efficacy of two commercially available prostaglandin analogues, misoprostol and dinoprostone as cervical ripening agents. Methods: Patients with a term, vertex, singleton pregnancy and a Bishop score of 4 or less were randomly assigned to receive misoprostol pessary (n = 35, 50 μg intravaginally, maximum dose of up to six pessary) or dinoprostone gel (n = 31, 0.5 mg intracervically; administered twice 6hrs apart). Patients were monitored throughout the period. If there was no progress in cervical dilatation or effective uterine contraction even after maximum dose of dinoprostone or misoprostol, patients were taken for cesarean section. Patients who were able to achieve Bishop’s score more than 7 but the delivery was not progressing, were augmented with intravenous oxytocin infusion. Result: Both drugs were found to be equally effective in improving Bishop’s score. There was significant reduction in the need for oxytocin augmentation in misoprostol (37.1%) group than in dinoprostone (67.7%) group. However, abnormal fetal heart rate was observed in 3 (8.6%) cases in misoprostol group and 2 (6.5%) in dinoprostone group. There was no statistically significant difference in meconium passage in two groups. But there were no significant differences in the mean induction to delivery time in dinoprostone and misoprostol group. Cesarean sections in dinoprostone and misoprostol groups were 32.3% and 28.6% respectively. No uterine hyperstimulation was observed, Apgar score less than 7 at 1 minute was 6 (19.4%) and 11 (31.4%) neonates in dinoprostone and misoprostol group and Apgar score less than 7 at 5 minutes was found only in one neonate of dinoprostone group. Conclusion: Vaginal misoprostol is an effective, safer and cheaper alternative to dinoprostone as a cervical ripening agent in underdeveloped countries with poor socioeconomic condition. DOI: http://dx.doi.org/10.3126jog.v3i2.10826 Nepal Journal of Obstetrics and Gynaecology Vol.3(2) 2008; 16-20
机译:目的:比较两种市售的前列腺素类似物米索前列醇和地诺前列酮作为宫颈成熟剂的安全性和有效性。方法:将足月,顶点,单胎妊娠且Bishop得分小于或等于4的患者随机分配接受米索前列醇子宫托(n = 35,阴道内50μg,最大剂量为六个子宫托)或地诺前列酮凝胶(n = 31) ,腹腔注射0.5毫克;间隔6小时给药两次)。在整个期间对患者进行监测。如果即使在最大剂量地诺前列酮或米索前列醇使用后,宫颈扩张或有效子宫收缩都没有进展,则将患者剖宫产。能够达到Bishop评分7分以上但分娩进展不佳的患者,可以静脉注射催产素。结果:发现这两种药物在改善Bishop得分方面都同样有效。与米诺前列酮(67.7%)组相比,米索前列醇(37.1%)组对催产素增加的需求显着减少。然而,米索前列醇组中有3例(8.6%)病例中观察到胎儿心率异常,而狄诺前列酮组中有2例(6.5%)观察到胎儿心率异常。两组胎粪通过率无统计学差异。但地诺前列酮和米索前列醇组的平均诱导分娩时间无显着差异。地诺前列酮和米索前列醇组的剖宫产分别为32.3%和28.6%。在狄诺前列酮和米索前列醇组中未观察到子宫过度刺激,Apgar在1分钟时得分低于7的分别为6(19.4%)和11(31.4%)新生儿,在5分钟时仅在1名Dinoprostone组中发现Apgar得分低于7。 。结论:在社会经济状况欠佳的欠发达国家中,阴道米索前列醇是代替地诺前列酮作为宫颈成熟剂的有效,安全和便宜的替代品。 DOI:http://dx.doi.org/10.3126jog.v3i2.10826尼泊尔妇产科学杂志,2008年,第3(2)期; 16-20

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号